Literature DB >> 19622597

Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials.

S-K Myung1, Y Kim, W Ju, H J Choi, W K Bae.   

Abstract

BACKGROUND: This meta-analysis aimed to investigate the effect of antioxidant supplements on the primary and secondary prevention of cancer as reported by randomized controlled trials.
METHODS: We searched Medline (PubMed), Excerpta Medica database, and the Cochrane Review in October 2007.
RESULTS: Among 3327 articles searched, 31 articles on 22 randomized controlled trials, which included 161 045 total subjects, 88 610 in antioxidant supplement groups and 72 435 in placebo or no-intervention groups, were included in the final analyses. In a fixed-effects meta-analysis of all 22 trials, antioxidant supplements were found to have no preventive effect on cancer [relative risk (RR) 0.99; 95% confidence interval (CI) 0.96-1.03). Similar findings were observed in 12 studies on primary prevention trials (RR 1.00; 95% CI 0.97-1.04) and in nine studies on secondary prevention trials (RR 0.97; 95% CI 0.83-1.13). Further, subgroup analyses revealed no preventive effect on cancer according to type of antioxidant, type of cancer, or the methodological quality of the studies. On the other hand, the use of antioxidant supplements significantly increased the risk of bladder cancer (RR 1.52; 95% CI 1.06-2.17) in a subgroup meta-analysis of four trials.
CONCLUSIONS: The meta-analysis of randomized controlled trials indicated that there is no clinical evidence to support an overall primary and secondary preventive effect of antioxidant supplements on cancer. The effects of antioxidant supplements on human health, particularly in relation to cancer, should not be overemphasized because the use of those might be harmful for some cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622597     DOI: 10.1093/annonc/mdp286

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  42 in total

1.  AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Authors:  Christoph Thomssen; Anton Scharl; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2011-08-30       Impact factor: 2.860

2.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

Review 3.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

4.  Drugs for preventing lung cancer in healthy people.

Authors:  Marcela Cortés-Jofré; José-Ramón Rueda; Claudia Asenjo-Lobos; Eva Madrid; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

5.  Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients.

Authors:  Leonardo Lisbôa da Motta; Carolina B Müller; Marco A De Bastiani; Guilherme A Behr; Fernanda S França; Ricardo F da Rocha; Juliane B Minotto; Rosalva T Meurer; Marilda C Fernandes; Adriana Roehe; Melissa M Markoski; Cristiano F Andrade; Mauro A A Castro; Fábio Klamt
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-22       Impact factor: 4.553

6.  Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centre.

Authors:  LeQuyen Luc; Charlotte Baumgart; Edward Weiss; Lesley Georger; Christine B Ambrosone; Gary Zirpoli; Susan E McCann
Journal:  Public Health Nutr       Date:  2014-05-27       Impact factor: 4.022

7.  Lifestyle and bladder cancer prevention: no consistent evidence from cohort studies.

Authors:  Alina Vrieling
Journal:  Eur J Epidemiol       Date:  2017-09-04       Impact factor: 8.082

Review 8.  "Only a Life Lived for Others Is Worth Living": Redox Signaling by Oxygenated Phospholipids in Cell Fate Decisions.

Authors:  Yulia Y Tyurina; Indira Shrivastava; Vladimir A Tyurin; Gaowei Mao; Haider H Dar; Simon Watkins; Michael Epperly; Ivet Bahar; Anna A Shvedova; Bruce Pitt; Sally E Wenzel; Rama K Mallampalli; Yoel Sadovsky; Dmitry Gabrilovich; Joel S Greenberger; Hülya Bayır; Valerian E Kagan
Journal:  Antioxid Redox Signal       Date:  2017-10-16       Impact factor: 8.401

Review 9.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

10.  Supplementation with tocotrienol-rich fraction alters the plasma levels of Apolipoprotein A-I precursor, Apolipoprotein E precursor, and C-reactive protein precursor from young and old individuals.

Authors:  Eng Chee Heng; Saiful Anuar Karsani; Mariati Abdul Rahman; Noor Aini Abdul Hamid; Zalina Hamid; Wan Zurinah Wan Ngah
Journal:  Eur J Nutr       Date:  2013-01-04       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.